CiRA Reporter

CiRA Reporter

Home › News & Events › CiRA Reporter › Director Koji Eto Shares His Vision Upon Assuming the Directorship

Focus

November 16, 2026

Director Koji Eto Shares His Vision Upon Assuming the Directorship

Director, Professor Koji Eto

Newly appointed Director Koji Eto transitioned from a practicing cardiologist to a full-time researcher after becoming fascinated by a fundamental question about platelets. Guided by his core philosophy of balancing basic research with clinical application, Dr. Eto aims to foster a supportive community where young researchers can speak openly and collaborate. Here is a closer look at his vision for the future of CiRA.
Driven by Simple Curiosity

My primary motivation for research has always been a pure, childhood curiosity: asking why?

Back when I was a cardiologist performing catheter interventions, I became intensely curious about platelets—the blood cells responsible for clotting. Why does this clumping suddenly occur in blood vessels when it normally doesn’t? Seeking answers led me to the United States, where I found myself captivated by the inverse challenge: generating platelets from scratch.

For the past 15 years at CiRA, I have worked on creating platelets and red blood cells from human iPS cells, always driven by that same fundamental curiosity. I believe it is vital to pursue those answers relentlessly—to keep pushing forward until you succeed, no matter how difficult the path may be.

Research and Application: Two Wheels of the Same Cart

CiRA’s core mission is embedded in its very name: pursuing both basic research and medical application. Delivering cell therapies and new medicines to patients remains our steadfast goal, regardless of leadership changes. However, clinical applications alone cannot sustain a research institute over the long term. Continuous innovation requires breakthroughs driven by our "rising stars"—the next generation of researchers.

That is why I want to create an environment where young scientists can recognize their own potential. We must help them develop their strengths and work together to find the ideal setting where those talents can flourish. Rather than leaving them to figure everything out on their own, we aim to offer proactive mentorship and thoughtful guidance. Ultimately, my goal is to build an environment that enriches the lives of every member of our institute.

A Community Where Everyone Can Speak Freely

My ideal is to build a community where people feel genuinely happy to be at CiRA. I think people tend to resist having views imposed on them, even when those views are reasonable. Breakthroughs happen in an environment where people respect one another and truly enjoy working together. When researchers feel comfortable voicing their opinions without hesitation, they discover perspectives they had never considered, and that mutual stimulation nurtures new ideas.

This fiscal year, we updated the format of our weekly institute-wide progress seminars to encourage livelier debate among young researchers. We allowed Q&A sessions to run without strict time limits and introduced facilitators to spark deeper discussions. I want everyone to feel fulfilled within this community while expanding their potential to the fullest.

Public Support Enables CiRA’s Bold Challenges

Public support through the iPS Cell Research Fund is what enables CiRA to pursue both basic research and clinical application. It is thanks to our donors that students and young researchers can tackle complex challenges based on their own ideas and utilize state-of-the-art facilities.

Moving forward, it is increasingly important for every member of our institute to cherish our connection with supporters through events like our appreciation gatherings. Furthermore, to broaden public understanding of our work, we must proactively communicate not only our research outcomes, but also our daily activities and underlying philosophy. Openly sharing these efforts helps build a lasting, heartfelt connection with our current donors and prospective supporters.

  1. Profile:  Koji Eto, M.D., Ph.D.
    (Director & Professor)


    After practicing as a cardiologist, Dr. Eto served as a Research Associate at Teikyo University Faculty of Medicine, a Postdoctoral Fellow at The Scripps Research Institute in the U.S., an Assistant Professor at the Institute of Medical Science at the University of Tokyo (IMSUT), and an Associate Professor at the IMSUT Stem Cell Bank. He became a Professor at CiRA in 2011 and assumed the position of Director in 2026. His research focuses on producing red blood cells and platelets from human iPS cells for clinical transfusion applications.
  2. Interviewed and written by Chiaki Yoshino
    A freelance writer based in Kyoto. She spent roughly a decade in various laboratory roles across corporations, universities, and research institutes. Capitalizing on her firsthand experience, she now works as a science writer. She has a portfolio of over 300 pieces, including interview profiles, press releases, and articles for corporate media.
    (Translation: Kelvin Hui Ph.D., CiRA Research Promoting Office)
go top